« Back to News

August 2, 2017

CAMRIS International Expands US Military Medical Research Support in Middle East and Africa

CAMRIS International has expanded services at the Naval Medical Research Unit – 3 (NAMRU-3) to reinforce the Operational Support and Investigational Research in Infection and Serology (OSIRIS) contract.  OSIRIS develops CAMRIS previous work on the Ancillary Services to Support Epidemiological Research Targets (ASSERT) contract by building upon CAMRIS assistance to the NAMRU-3 Global Disease Detection and Response Program (GDDRP) with the Center for Disease Control (CDC) to now include support services to additional research programs including:

  • Bacterial and Parasitic Diseases Research Program

  • Viral and Zoonotic Diseases Research Program

  • Vector Biology Research Program

The Naval Medical Research Unit No. 3 (NAMRU-3) is the largest U.S. overseas military medical research facility.  Based in Cairo, Egypt since 1946, NAMRU-3’s mission is to study, monitor, and detect emerging and re-emerging disease threats of military and public health importance; develop mitigation strategies against these threats in partnership with host nations, international and U.S. agencies in CENTCOM, EUCOM and AFRICOM areas of responsibility.  Staff develop and test vaccines and therapeutic agents, evaluate diagnostic assays and advance vector control measures. NAMRU-3 plays a key role in surveillance of pathogens in its Area of Responsibility (AOR) and in providing outbreak assessment and support mission.  CAMRIS provides support and travel for basic and clinical research efforts, surveillance, vaccine efficacy, performance and evaluation of new diagnostic capabilities, and research report development conducted in consonance with the mission of NAMRU-3.

OSIRIS reinforces the collaboration between NAMRU-3, CDC, International Emerging Infections Program (IEIP) and the Arab Republic of Egypt Ministry of Health (MOPH), to support obligations under joint agreements to detect, prevent and respond to infectious diseases of national and international importance through the GDDRP Contract. The Damanhour District, located in the Delta region of Egypt with approximately 750,000 residents, was selected as the site for a collaborative effort between NAMRU‐3, CDC, International Emerging Infections Program (IEIP) and the Egyptian Ministry of Health to establish a population‐based surveillance site for respiratory pathogens, diarrhea, acute febrile illness, tuberculosis and acute neurological infectious disease. GDDRP supports the MOPH in Field Epidemiology Training Program (FETP) development by providing technical assistance and provision in the areas of surveillance, epidemiology, outbreak response, and applied public health research. OSIRIS oversees all activities related to a variety of special projects beyond the platform of the Population-based Surveillance for Selected Infectious Diseases protocol in Damanhour.

Regarding the new award Ms. April Lueben, CAMRIS Director of Military Medicine, said, “CAMRIS is honored to be expanding our international military medicine support services for NAMRU-3.  The OSIRIS contract provides our team with the opportunity to extend their infectious disease research to additional countries in northern Africa, which had previously been supported in Egypt, Djibouti and Yemen.”